US Broker Ratings

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Unveiling a Potential 270.71% Upside in Biotech

Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company, is generating buzz in the healthcare sector with its focus on innovative gene and cell therapies. Specializing..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Unpacking a Potential 219% Upside in the Biotech Sector

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a promising player in the biotechnology industry, has captured the attention of investors with its significant projected upside potential. Specializing..

TotalEnergies SE (TTE) Stock Analysis: Exploring a 13.81% Upside with Strong Dividends and Strategic Diversification

TotalEnergies SE (TTE), a French multinational energy giant, represents a compelling opportunity for investors interested in diversifying their portfolios within the oil and gas sector. With..

Immutep Limited (IMMP) Stock Analysis: Biotechnology Innovator with a 348% Potential Upside

Immutep Limited (NASDAQ: IMMP), the Australian biotechnology firm, is making waves in the healthcare sector with its innovative approach to immunotherapy. The company’s focus is on..

Quantum-Si Incorporated (QSI) Stock Analysis: Exploring the Healthcare Innovator’s Growth Potential

Quantum-Si Incorporated (QSI) is making waves in the healthcare sector, with its innovative approach to Next Generation Protein Sequencing (NGPS). Based in Branford, Connecticut, Quantum-Si is..

Exxon Mobil (XOM) Stock Analysis: Assessing Its 11.97% Potential Upside Amid a Challenging Market

Exxon Mobil Corporation (NYSE: XOM), a titan in the energy sector, continues to capture investor attention as it navigates the evolving landscape of oil and gas..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring a 154% Upside Potential in Biotechnology

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company based in Singapore, has caught the attention of investors with its innovative approach to RNA medicines..

Evolent Health, Inc (EVH) Stock Analysis: Exploring a 101% Potential Upside Amidst Market Challenges

Evolent Health, Inc. (NYSE: EVH) is making waves in the healthcare sector with a compelling proposition for investors, boasting a potential upside of 101.32% based on..

MiMedx Group, Inc. (MDXG) Stock Analysis: A Biotech Play with 87% Potential Upside

MiMedx Group, Inc. (NASDAQ: MDXG) is drawing significant attention in the biotechnology sector with its innovative approach to healthcare solutions. The company, based in Marietta, Georgia,..

AdaptHealth Corp. (AHCO) Stock Analysis: Is a 50.86% Potential Upside Worth the Investment?

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector, specializes in the distribution of home medical equipment and related services within the United States...

Pulse Biosciences, Inc (PLSE): Investor Outlook with a 26.95% Potential Upside

Pulse Biosciences, Inc (NASDAQ: PLSE), a pioneering force in the healthcare sector, has captured investor attention with its innovative bioelectric medicine technologies. Headquartered in Miami, Florida,..

Omnicell, Inc. (OMCL) Stock Analysis: Navigating Healthcare Automation with a 49.36% Upside Potential

Omnicell, Inc. (NASDAQ: OMCL), a key player in the healthcare sector, stands at the intersection of technology and medication management. With a market capitalization of $1.35..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: Navigating Growth with a 16.8% Revenue Surge

Aveanna Healthcare Holdings Inc (AVAH), a prominent player in the healthcare sector, continues to capture investor attention with its impressive revenue growth of 16.8%. Headquartered in..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Assessing Its Growth Potential Amidst Healthcare Challenges

Pediatrix Medical Group, Inc. (NYSE: MD) is a prominent player in the healthcare sector, specifically within the medical care facilities industry in the United States. With..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: A 37% Upside in the Biotech Pipeline

Travere Therapeutics, Inc. (TVTX) stands out in the biotechnology sector, not only for its niche focus on rare kidney and metabolic diseases but also for the..

agilon health, inc. (AGL) Stock Analysis: Exploring 36% Potential Upside Amidst Healthcare Challenges

agilon health, inc. (NYSE: AGL) has been capturing the attention of investors with its unique approach to healthcare services for seniors through a network of primary..

MannKind Corporation (MNKD) Stock Analysis: Assessing a 103% Potential Upside in the Biotech Sector

MannKind Corporation (NASDAQ: MNKD), a leading player in the biotechnology sector, has captured investor attention with its promising therapeutic products targeting endocrine and orphan lung diseases...

Indivior PLC (INDV) Stock Analysis: Evaluating a 22% Potential Upside in Healthcare

Indivior PLC (INDV), a prominent player in the healthcare sector, holds a pivotal position within the specialty and generic drug manufacturing industry. With a market cap..

Harrow, Inc. (HROW) Stock Analysis: Eyeing a 75.84% Upside in the Healthcare Sector

Harrow, Inc. (NASDAQ: HROW), a Nashville-based pharmaceutical company, has caught the eye of investors with its robust potential upside of 75.84%, according to recent analyst ratings...

Pacira BioSciences, Inc. (PCRX) Investor Outlook: A 30% Upside Potential Amidst Healthcare Innovation

Pacira BioSciences, Inc. (NASDAQ: PCRX) presents a compelling case for investors with its innovative approach to pain management solutions and a significant upside potential of 30.28%..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds